Why Webuy Global Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Webuy Global shares jumped 15% premarket after H1 revenue nearly doubled to $14.31M and net loss narrowed; Game Your Game led gainers, Masonglory fell.
Stocks · News reference
Polaryx Therapeutics Says It Remains On Track To Initiate Phase 2 SOTERIA Basket Trial Of PLX-200 In Four Pediatric Lysosomal Storage Disorders In Q4 2026
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — Polaryx Therapeutics, Inc. (PLYX)
Filed: 2026-09-01 AccNo: 0001213900-26-096235 Size: 218 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Polaryx Therapeutics shares are trading higher after Raymond James initiated coverage on the stock with a Strong Buy rating and announced a $6 price target.